Polivy Approved for Previously Untreated DLBCL, Not Otherwise Specified, or High-Grade B-Cell Lymphoma

The FDA approved polatuzumab vedotin-piiq (Polivy, Genentech) with R-CHP (rituximab, cyclophosphamide, doxorubicin, ...

APRIL 21, 2023